Molecular mechanisms underlying the promotion of antibacterial immunity by LC3-associated phagocytosis
Molecular mechanisms underlying the promotion of antibacterial immunity by LC3-associated phagocytosis
批准号:
432240111
负责人:
Professor Dr. Olaf Utermöhlen, since 4/2021
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2019
资助国家:
德国
项目状态:
已结题
起止时间:
2018-12-31 至 2023-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Phagocytosis of invading bacteria by neutrophils and macrophages is a key component of antibacterial immunity. In the phagosome, the bacteria are inactivated, killed and degraded. Some pathogens, such as Mycobacterium tuberculosis or Listeria monocytogenes, however, have evolved mechanisms that prevent their killing in conventional phagosomes. We have recently identified a non-canonical autophagy pathway called LC3-associated phagocytosis (LAP) that allows macrophages to effectively kill phagocytosed L. monocytogenes (Gluschko et al., Cell Host & Microbe 2018). LAP also is crucial for elimination of other microbial pathogens, such as M. tuberculosis or Aspergillus fumigatus, indicating that it generally represents a particularly microbicidal pathway. During LAP, phagosomes are decorated by the protein LC3, which enhances the fusion with lysosomes and thus the killing of the phagocytosed pathogen. However, only a subpopulation of pathogen-containing phagosomes is targeted by LAP and decorated with LC3. Hence, the high antimicrobial potential of LAP is not fully retrieved. Therapeutic approaches based on increasing the targeting of phagocytosed pathogens by LAP would therefore potentially markedly enhance cell-mediated antibacterial defense.The objective of this project is to further elucidate the molecular mechanisms of LAP induction and thereby identify potential starting-points for using the superior microbicidal activity of this cellular mechanism in the treatment of microbial infections.Illustrating that promoting LAP may be a promising strategy for enhancing cell-mediated antibacterial defense, our preliminary data show that the targeting and killing of L. monocytogenes by LAP is substantially increased by the proinflammatory cytokine tumor necrosis factor (TNF). Thus, TNF is an endogenous promotor of LAP and, thereby, antibacterial defense. The first specific aim of this project is to decipher the molecular mechanisms through which TNF promotes LAP induction.Regarding the induction of LAP, we and others have shown that reactive oxygen species (ROS) produced by the NADPH oxidase Nox2 are critically required. In addition to their well-known direct function in killing of phagocytosed pathogens, ROS also exert regulatory functions. How the ROS induce the recruitment of LC3 to phagosomes by LAP, however, remains completely elusive. The second specific aim of this project therefore is to unravel the molecular mechanism through which ROS induce LAP.The insights gained by this project into how macrophages bring to use the particularly microbicidal mechanism of LAP will substantially further our understanding of cell-mediated antimicrobial immunity and identify potential starting-points for novel therapeutic approaches based on increasing the targeting of phagocytosed pathogens by LAP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
-
批准号:82371255
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹立
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
-
批准号:82372015
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:熊丽琴
-
依托单位:
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位: